Comprehensive Outlook on Executive Summary Metastatic Solid Tumors Market Size and Share CAGR Value Data Bridge Market Research analyses a growth rate in the global metastatic solid tumors market in the forecast period 2022-2029 Metastatic Solid Tumors Market research report unearths different industry verticals such as company profile, contact details of manufacturer, product...

What is Driving the Growth of the Artificial Intelligence in Oncology Market? The global artificial intelligence in oncology market was valued at USD 2.51 billion in 2024 and is projected to reach USD 31.05 billion by 2034, growing at a CAGR of 28.60% from 2025 to 2034. This impressive growth is primarily driven by the rising demand for early and accurate cancer detection, AI integration in...

Breast Cancer Liquid Biopsy Market Overview The global breast cancer liquid biopsy market size was valued at USD 103.03 million in 2022. It is projected to reach USD 474.62 million by 2031, growing at a CAGR of 18.50% during the forecast period (2023-2031).  Download Exclusive Research Report PDF Sample: (Including Full TOC, List of Tables & Figures, Chart)...

"Regional Overview of Executive Summary Cancer Biologics Market by Size and Share CAGR Value The global cancer biologics market size was valued at USD 122.55 billion in 2024 and is projected to reach USD 195.62 billion by 2032, with a CAGR of 6.02% during the forecast period of 2025 to 2032. Deliberately analyzed facts and figures of the market and keen business insights mentioned in...

Capecitabine market, an oral chemotherapy drug classified as an anti-metabolite, is converted into fluorouracil in the body, inhibiting cancer cell DNA synthesis. It is primarily used to treat breast cancer, colorectal cancer, gastric cancer, and pancreatic cancer, offering a targeted approach to managing these malignancies. The capecitabine market is driven by the rising cancer prevalence,...

Overview Cell and Gene Therapies are revolutionary approaches in treating diseases at their roots. These therapies work by either modifying genes (gene therapy) or manipulating cells (cell therapy), often combining both methods—for instance, gene‐modified cell therapies like CAR‑T, where a patient’s T cells are genetically engineered to target cancer cells. The market includes...

"What’s Fueling Executive Summary Display Controllers Market Size and Share Growth CAGR Value The global display controllers market size was valued at USD 37.59 billion in 2024 and is expected to reach USD 78.73 billion by 2032, at a CAGR of 9.68% during the forecast period. To formulate an all-inclusive Display Controllers Market report, detailed...

"Executive Summary Hereditary Cancer Testing Market : CAGR Value Data Bridge Market Research analyzes that the global hereditary cancer testing market is expected to reach the value of USD 13,085.04 million by 2029, at a CAGR of 12.9% during the forecast period. This market report also covers pricing analysis, patent analysis, and technological advancements in depth. The Hereditary...

The Global Cancer Gene Therapy Market  was valued at US$ 2.1 billion in 2023 and is projected to reach US$ 7.8 billion by 2031, registering a CAGR of 17.5% during the forecast period 2024–2031. Market growth is primarily driven by the increasing prevalence of cancer worldwide, coupled with the growing demand for targeted and personalized treatment modalities beyond conventional...

The global Oncology Drugs Market is undergoing a dynamic transformation, driven by the rising incidence of cancer, advancements in therapeutic innovation, and increased healthcare spending across developed and emerging nations. As governments and private organizations continue to invest in cancer research, the demand for effective oncology drugs is witnessing substantial growth. According to...